| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.086 | 0.009 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.009 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.009 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.069 | 0.009 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |